All tenders
75N93026C00010
TO DEVELOP AND CLINICALLY VALIDATE AN INNOVATIVE CELL-FREE DEOXYRIBONUCLEIC ACID (CFDNA) BASED PANEL FOR DETECTING DISEASE-CAUSING FUNGI DIRECTLY FROM PLASMA.
Department of Health and Human Services · MN, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93026C00010
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- TO DEVELOP AND CLINICALLY VALIDATE AN INNOVATIVE CELL-FREE DEOXYRIBONUCLEIC ACID (CFDNA) BASED PANEL FOR DETECTING DISEASE-CAUSING FUNGI DIRECTLY FROM PLASMA.
- Source
- usaspending
- Source ID
- CONT_AWD_75N93026C00010_7529_-NONE-_-NONE-
Details
- Location
- MN, United States
Description
TO DEVELOP AND CLINICALLY VALIDATE AN INNOVATIVE CELL-FREE DEOXYRIBONUCLEIC ACID (CFDNA) BASED PANEL FOR DETECTING DISEASE-CAUSING FUNGI DIRECTLY FROM PLASMA. Awarded to: ZEPTO LIFE TECHNOLOGY, INC. Sub-agency: National Institutes of Health Contract type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/08/03 12:00:00 AM UTC
- Closing date
- 2027/04/30 12:00:00 AM UTC
Estimated value
$1.9M USD
Classification
Normalized category
Other